Teva(IL:TEVA)
ILAÂ 14,150.00+120.00 (+0.86%)
IL:TEVA
Teva earnings date
ILAÂ 14,150.00
At close:+120.00 (+0.86%)
Want to see IL:TEVA full AI Analyst Report?
Teva (TEVA) Q1 2023 Earnings Report
63 Followers
IL:TEVA Q1 2023 EPS Results
- Actual EPS
- ILA 129.75
- Consensus EPS
- ILA 180.67
- Beat/Miss
- Missed by -ILA 50.93
- One Year Ago EPS
- ILA 178.40
IL:TEVA Q1 2023 Revenue Results
- Actual Revenue
- ILA 1.29T
- Expected Revenue
- ILA 1.17T
- Beat/Miss
- Beat by +ILA 117.75B
- YoY Revenue Growth
- +10.90%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 05/10/2023
- Time
- Before Open
- Conference Call
- Wednesday, May 10, 2023
IL:TEVA Upcoming Earnings
Teva's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q1 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:TEVA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | 215.38- | 311.39 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 233.87278.95 | 253 | 10.26% (+25.95) | |
| Jul 29, 2026 | 2026 (Q2) | 16.876.49 | 214.08 | -96.97% (-207.59) | |
| Apr 29, 2026 | 2026 (Q1) | 152.78171.91 | 168.67 | 1.92% (+3.24) | |
| Jan 28, 2026 | 2025 (Q4) | 207.92311.39 | 230.3 | 35.21% (+81.09) | |
| Nov 05, 2025 | 2025 (Q3) | 223.81253.00 | 223.81 | 13.04% (+29.19) | |
| Jul 30, 2025 | 2025 (Q2) | 200.13214.08 | 197.86 | 8.20% (+16.22) | |
| May 07, 2025 | 2025 (Q1) | 149.86168.67 | 155.7 | 8.33% (+12.97) | |
| Jan 29, 2025 | 2024 (Q4) | 229.33230.30 | 324.36 | -29.00% (-94.07) | |
| Nov 06, 2024 | 2024 (Q3) | 214.41223.81 | 194.62 | 15.00% (+29.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

